Introduction
Interleukin-10 (IL-10) is a multi-functional cytokine which is one of the key elements of the immune system. 1 Originally defined as 'cytokine synthesis inhibitory factor', 2 it is generally held to have antiinflammatory actions through its ability to downregulate antigen-presentation and macrophage activation in response to several stimuli.
3, 4 Awareness of this regulatory role has been strengthened by the discovery of regulatory T cells (Tr1-cells) demonstrating immunosuppressive functions both in vitro and in vivo, whose development and function depend on IL-10.
human pathogenic viruses; the long-recognised EpsteinBarr virus (EBV) homologue 8, 9 was recently mirrored in the discovery of a cytomegalovirus (CMV) IL-10 homologue. 10 IL-10 plays an important role in several human diseases. Its ability to promote B-cell activation and autoantibody production 11, 12 has led to the definition of possible roles for IL-10 in the pathophysiology of systemic lupus erythematosus (SLE) at both functional 13 and genetic [14] [15] [16] levels; similar mechanisms might apply to the involvement of IL-10 in rheumatoid arthritis (RA). [17] [18] [19] In human malignant disease, IL-10 has a more ambiguous role. It has been shown that IL-10 suppresses T-cell responses in some malignant conditions 20 and that high expression of IL-10 can be observed in metastatic tissues. 21 On the other hand, through its ability to inhibit the expression of matrix-metalloproteinases, IL-10 is capable of preventing the seeding of tumour cells into tissue 22 and in this activity, as well as others 23 might therefore be said to give IL-10 an 'anti-metastatic' function. This activity may be mediated by IFN-␥, 24 since the anti-tumour activity of IL-10 is lost in mice where the IFN-␥ gene is deleted.
Many cytokines exist within structurally-related families. An example of this is the tumour necrosis factor (TNF) family of ligands which comprises three adjacent, closely-related genes within the MHC region on chromosome 6 25 and many other genes on a variety of chromosomes, which continue to be uncovered. 26, 27 More recently, the T-cell-derived cytokine IL-17 was shown to be the prototype for a new family of cytokines. 28 Given the wide range of activities of IL-10 and recognising that families of cytokines exist, we speculated that IL-10 too might be one member of a family of IL-10 related cytokines. In this report, we describe a human homologue of IL-10 and discuss the structure of its gene and protein in relation to IL-10 itself and other IL-10 homologues, and compare the expression of its mRNA with that of IL-10 in activated macrophages. We designated this new IL-10 homologue 'IL-19'.
Results

IL-19 is a novel human homologue of human IL-10
In two independent, parallel experiments utilising either the Genbank or TIGR databases, we identified the following ESTs as potentially encoding IL-10 homologues: AI266722, AA151656 and AA151652; the Genbank database also yielded ESTs AA151736 and AA151733. Following the screening of an EBV-transformed B-cell library, a full-length cDNA of approximately 1000 bp was obtained. The cloned cDNA ( Figure 1a ) encoded a protein of 177 amino acid residues. A hydropathy plot of the protein suggested the presence of a signal peptide of about 18-20 amino acids at the N-terminus of the IL-10 homologue.
Alignment of the amino acid sequence of the protein, which we designated IL-19, with those of human IL-10 and cmvIL-10 ( Figure 1b) revealed common structural features. The BLAST similarity between IL-10 and IL-19 is shown between the two sequences, while the recentlydescribed cmvIL-10 is shown above (uppercase where The areas forming the helices of human IL-10 are shown and a strong similarity of IL-19 is apparent. Residues previously determined to be important for the interaction of human IL-10 with the IL-10R1 receptor chain 30 are illustrated with a star (*); those residues identical or similar in human IL-19 are shown with a bold star (*). For comparison, the peptide sequence of cmvIL-10 is also shown. This molecule has been demonstrated to signal through the human IL-10 receptor. 10 Amino acids in cmvIL-10 which are identical or similar to those of human IL-10 are shown in upper case. It will be seen that cmvIL-10 shares greater homology with human IL-10 in those areas of interaction with the IL-10R1 receptor chain than does human IL-19. The functionally-relevant amino acid Ile87 is indicated with an arrowhead. Although this is conserved in human IL-19, this area of IL-19 is less closely-related to human IL-10 than is cmvIL-10, supporting the observation that IL-19 does not signal through the canonical IL-10 receptor complex.
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homologous or similar, lower case otherwise. Note that gaps are introduced in the cmvIL-10 to allow for the principle analysis, IL-19 vs IL-10). The four cysteine residues necessary to fold the IL-10 monomer correctly 29 are conserved ( Figure 1b ) and very high amino-acid matching is present towards the C-terminus. In addition, there is excellent conservation of the length of all IL-10 helices and inter-helix regions in the IL-19 molecule, suggesting that it adopts a similar folded structure to that of IL-10. Furthermore, 82% of the 50 amino-acids previously determined to be components of the hydrophobic core 
IL-19 mRNA has a complex 5′ untranslated region
We have sequenced IL-19 cDNA clones from several sources, including stimulated peripheral blood mononuclear cells and an EBV-transformed B-cell library; the longest cDNA sequences obtained are reported here. In addition, genomic sequence 5′ of the ATG coding for the methionine present in both the cDNA clones was obtained from genome walking experiments. Interestingly, these experiments yielded three distinct sequences, as shown in Figure 3 . Two cDNAs have different 5′-sequences, neither of which is contiguous with the genomic segment which describes the first translated sequence. The sequences diverge starting two nucleotides -GC -upstream from the ATG codon. The genomic sequence has a consensus 3′ splice acceptor site motif '(C/T)n.N.(C/A).A.G' -adjacent to these two nucleotides, indicating that there could be an intron close to the ATG codon. These data suggest that the human IL-19 gene can be alternatively-spliced upstream of this specific ATG codon, or alternatively be transcribed from two different promoters. The longer 5′ sequence (Figure 3 ) contains a potential alternative translation site (doubleunderlined), in-frame with the main peptide sequence. The effect of beginning translation with this additional methionine is to add the following sequence to the amino-terminus of the translation product shown in 
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Regulation of human IL-19 mRNA in human monocytes IL-10 gene expression can be induced by a variety of stimuli, including LPS, in human monocytes. 2 The appearance of IL-10 mRNA in LPS-stimulated monocytes is delayed relative to that of other LPS-inducible genes such as TNF-␣ and IL-1. 32 Since IL-19 expression was induced following LPS-stimulation of unseparated PBMC, it is important to understand its control in purified human monocytes. To determine if expression of IL-19 mRNA in LPS-stimulated monocytes coincides with expression of IL-10 mRNA, we incubated purified monocytes with medium alone or LPS (100 ng/ml) for 0 to 4 h. At designated time points, the cells were harvested, RNA was isolated, and the levels of IL-19 and IL-10 mRNA were measured by Northern blotting. As shown in Figure 4a , LPS stimulation induced expression of IL-19 mRNA which was not detectable until 4 h poststimulation. Although significant levels of IL-10 mRNA were detectable at 2 h post-stimulation, IL-19 mRNA was not detectable until 4 h post-treatment.
The level of IL-19 gene expression induced by treatment of monocytes with LPS alone was relatively low. To determine if costimulating monocytes with certain cytokines together with LPS results in increased IL-19 gene expression, we preincubated monocytes with medium alone (control), IFN-␥, IL-4, or IL-13 for 2 h. We then added LPS and incubated the cells for an additional 3 h. At the end of the second incubation period, the cells were harvested, RNA was isolated, and the levels of IL-19 and IL-10 mRNA were examined by Northern blotting. As shown in 
Discussion
We have isolated and characterised a novel cDNA whose encoded protein is identified as a homologue of human interleukin-10. This cDNA is contained within a gene whose exon/intron structure is similar to that of the human IL-10 gene. The cDNA is expressed in human macrophages following LPS stimulation and this expression is regulated by cytokines that are known to modulate the expression of IL-10. No evidence for strong IL-19 expression in activated T-cells was observed. The new protein is capable of being secreted and glycosylated during transient production in transfected COS cells. We have termed this new gene 'IL-19'.
There is marked similarity between IL-19 and IL-10. The two proteins are of similar length (159 and 160 amino acids respectively, with additional leader sequences of 18 amino acids in each case). They appear to conform to an identical six-helix structure, each stabilised by two disulphide bonds whose positions are exactly conserved. IL-19 appears to have an identical hydrophobic core as IL-10 and when considered with the other structural similarities this suggests that it too is stable as a homodimer. Interestingly, those amino-acids present in the hydrophobic core region of IL-19 which are not homologous to those in IL-10, correspond to those in positions previously defined to take no part in the hydrophobic interactions within the IL-10 molecule, 29 further emphasising the similarity between those which do match. Despite this strong structural similarity, IL-19 shows only moderate similarity to IL-10 in those regions corresponding to parts of the IL-10 molecule which were predicted to interact with IL-10R1. 30 Thus, IL-19 is unlikely to constitute an alternative ligand for the IL-10 receptor. This contrast is emphasised by a comparison with the recently-identified IL-10 homologue found in cytomegalovirus, cmvIL-10.
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The IFN-␥ and IL-10 receptor complexes are structurally homologous. [33] [34] [35] [36] Although to date only the crystal structure of the complex between IFN-␥ and its soluble IFN-␥ R1 receptor has been solved, 37 based on the structural homology of the ligands and the receptor complexes 29,30,37-39 a number of residues of IL-10 were proposed to be involved in interaction with the receptor. 30 The sequence of cytomegalovirus-encoded IL-10 (cmvIL-10) is included in the alignment because it provides additional information due to unique features of this protein. It was recently demonstrated that despite the low homology between IL-10 and cmvIL-10 (26% identity), cmvIL-10 binds and signals through the IL-10 receptor complex and competes for the receptor binding sites with IL-10. 10 Thus, it is likely that the residues participating in interaction with the receptor should be conserved between IL-10 and cmvIL-10. Residues of IL-10 believed to be involved in interaction with the IL-10 receptor first chain are marked with asterisks and those which are conserved or similar in IL-19 are marked in bold asterisks. The alignment shows that a number of the residues for IL-10/receptor interaction which are not conserved in IL-19 are in fact conserved in the cmvIL-10 molecule, further indicating that IL-19 is unlikely to interact competently with the IL-10 receptor. Furthermore, IL-19 is less similar to IL-10 in the regions flanking the IL-10 residue Ile87 than is cmvIL-10. This amino-acid is known to be critical to the function of IL-10 40 and might interact with the IL-10 receptor second chain. Indeed, preliminary experiments have failed to demonstrate competition between IL-19 and IL-10 for the IL-10 receptor (SVK and SP, data not shown).
It is noteworthy that IL-19 cDNAs isolated from freshly-stimulated human PBMCs differed in their immediate 5′-sequences and that these, too, varied from the genomic sequence immediately upstream of the codon for the methionine present in both the cDNA clones. In the genomic sequence there is a 3′ intron/exon splice-acceptor site two nucleotides upstream of the ATG codon, suggesting the possibility of an intron in the IL-19 5′-UTR. An examination of genomic sequence at the site of the 5′ sequence of the shorter cDNA shows a consensus intronic 5′ motif, exactly as required to permit splicing of this element to the coding exon. However, no evidence exists to suggest that the genomic DNA upstream of this shorter 5′-UTR could function as an inducible or constitutive promoter (not shown). The sequence encoding the most 5′-region of the longer cDNA is approximately 25 Kb further upstream in the genome from the sequence of the shorter cDNA. This also has a consensus 5′ intronic motif which allows it to be spliced in-frame with the exon of the coding sequence. Beginning translation from this additional ATG codon would lead to a longer leader sequence on the IL-19 protein (Figure 3 ) and preliminary evidence suggests that this form is not as readily secreted as that produced from the mRNA coding for the shorter form. Thus it appears that the IL-19 mRNA is subject to more complex processing than that of IL-10, where there are no known alternative translation start sites. This matter remains to be resolved but is very reminiscent to the situation seen with IL-15. Interleukin-15 was also reported to be expressed from two alternative promoters, one of which also generates a longer leader sequence. The shorter leader sequence is more poorly translated and furthermore appears unable to be secreted. 41 The longer leader sequence drives post-translational modification producing several IL-15 isoforms, one of which is translocated to the nucleus and another of which is ultimately secreted (as reviewed in Waldmann and Tagaya   31 ). The degree to which the regulation of many of these cytokines generally is so complex is not yet known. However, while many cytokines have uncomplicated promoter structures, it is becoming apparent that complex alternative splicing and promoter usages (including intronic promoters) may be frequent in molecules used by the immune system. Of particular note are the many alternative splice forms from the LST-1 gene in the TNF cluster, 42 the use of alternative promoters in the oncostatin-M gene 43 and the CCR5 gene. 44 Indeed, the complex genetic nature of the human IL-10 promoter and its role in IL-10 secretion, may be an other reflection of this phenomenon. [45] [46] [47] The observation that neither of the IL-19 mRNA 5′ elements was contiguous with the genomic segment for the first coding exon suggests that IL-19 may also have a complicated regulation, perhaps varying in different cell-types.
The appearance of IL-19 mRNA in LPS-stimulated monocytes coincided with expression of IL-10 mRNA. Unlike other LPS-inducible cytokine genes such as TNF-␣ and IL-1, which are expressed within 1 h post-stimulation (not shown), mRNA for the IL-19 and IL-10 genes is not detectable until 2-3 h post-stimulation. This delayed induction of IL-19 and IL-10 gene expression is consistent with a role for these cytokines as feedback inhibitors of proinflammatory cytokine production. Previous studies have shown that blockade of IL-10 activity with neutralising anti-IL-10 Abs markedly increases TNF gene expression and TNF production.
3, 32 The fact that inhibition of TNF expression cannot be completely reversed by anti-IL-10 Abs indicates that other IL-10-like cytokines may be produced by LPS-stimulated monocytes.
Although treatment of monocytes with IL-4 and IL-13 alone did not induce de novo expression of IL-19, these cytokines did potentiate IL-19 gene expression in LPSstimulated monocytes. Priming monocytes with IL-4 or IL-13 also amplified expression of IL-10 mRNA in LPSstimulated monocytes. These findings are consistent with a recent report, 48 which demonstrated that IL-4 and IL-13 can increase IL-10 production by LPS-stimulated murine macrophages. IL-4 and IL-13 inhibit production of proinflammatory cytokines such as TNF and IL-1 by monocytes.
3,49,50 Our finding that IL-4 and IL-13 amplify IL-10 and IL-19 gene expression in cultures of LPS-stimulated monocytes may explain how IL-4 and IL-13 inhibit production of cytokines such as TNF and IL-1. Although most of the cytokines that we tested did not induce IL-19 gene expression unless the cells were costimulated Genes and Immunity with LPS, GM-CSF was capable of directly inducing IL-19 gene expression in monocytes. These findings are compatible with a related study by Lehmann et al, 51 which demonstrated that GM-CSF can induce IL-10 expression in the monocytic cell line U937.
The presence of this new cytokine, a homologue of IL-10, raises questions about the complexity of immunosuppression which will only be answered by further experimentation. The initial screens for IL-19 revealed ESTs which were obtained from pregnant uterine cDNA and we cloned the mRNA from EBV transformed B-cells. It is known that during pregnancy immunity of the mother is shifted toward Th2 type of immune response; 52, 53 IL-19 may be the cytokine contributing to this shift. In addition, we have cloned the IL-19 cDNA from EBV-transformed lymphocytes, suggesting that IL-19 could be expressed by EBV-infected cells. It is known that both EBV-encoded and host IL-10s are expressed by virus infected cells. Expression of IL-19 could therefore contribute to the local suppression of the immune response mediated by IL-10-type immunosuppressive molecules. Furthermore, during the preparation of this manuscript we became aware of two independent reports also identifying IL-10 homologues. A protein designated 'IL-TIF' is expressed by IL-9 treated murine T-cells 54 and an IL-10 homologue designated 'AK-155' was cloned as a protein expressed by herpesvirus saimirie-transformed T-lymphocytes. 55 Thus, the identification of IL-19 extends the family of IL-10-related proteins, bringing the number of family members to four.
Our preliminary data suggest that IL-19 does not utilise the IL-10 receptor complex for signaling. However, it is possible that it may share one of the subunits of the IL-10 receptor complex, particularly IL-10R2, requiring distinct, ligand-specific additional receptor chains. A number of orphan receptors from the class-II cytokine receptor family (to which both subunits of the IL-10 receptor belong) have been identified 35 and are strong receptor candidates for these new cytokines. Thus IL-10, like so many other cytokines, exists within the framework of a family of cytokines which may have related, but subtly distinct, activities.
Materials and methods
Cloning of the IL-19 mRNA
In parallel experiments, the Genbank and TIGR databases were interrogated for sequences similar to IL-10. Each of the identified cDNAs encoded part of the c-terminus of a protein and the 3′ untranslated portion of its cDNA. The contig of these ESTs was used to design primers for cloning a full-length IL-10 homologue cDNA by nested PCR from a library containing cDNA from EBV transformed human B-lymphocytes (Clonetech, catalogue number HL4006AE). under the following conditions: denaturation at 94°C for 4 min followed by 35 cycles of 94°C, 1 min; 55°C 1 min; 72°C, 1 min; and completed with a final extension step at 72°C for 10 min. This probe was radiolabeled by the random primer method 56 to a specific activity of 10 8 cpm/g or greater.
Normal human peripheral blood monocytes were isolated by countercurrent centrifugal elutriation in a Beckman JE-6B centrifugal elutriator (Beckman Instruments, Inc., Fullerton, CA, USA) as previously described. 57 The elutriated monocyte fraction consisted of Ͼ95% monocytes as determined by histologic staining and FACS analysis after labelling with the anti-CD14 mAb, Leu M3 (Becton Dickinson, Mountain View, CA, USA). Monocytes were routinely cultured at 4 × 10 6 cells/ml in complete medium in round-bottom, polypropylene tubes (17 × 100 mm).
Monocytes were cultured in RPMI-1640 medium (GIBCO-BRL, Gaithersburg, MD, USA) supplemented with 10% (v/v) heat-inactivated foetal calf serum (Hyclone, Logan, UT, USA), 2 mm L-glutamine, and 50 mg/ml gentamycin (Complete Medium). Recombinant human IL-4 and rhIL-10 were provided by ScheringPlough, Inc (Kenilworth NJ, USA). Recombinant human IL-13 was obtained from BioSource International (Camarillo, CA, USA). Recombinant human IFN-␥ was provided by Genentech, Inc (So. San Francisco, CA, USA). Recombinant human IFN-␤ was provided by Chiron Corp (Emeryville, CA, USA).
Total RNA was isolated from cultured monocytes by the acid guanidinium thiocyanate-phenol-chloroform extractionmethod as previously described. 58 RNA precipitates were pelleted by microcentrifugation, and redissolved in 100 L of DEPC-treated sterile water. After quantitation by spectrophotometry, equivalent amounts of RNA (10 g/lane) were size-fractionated by electrophoresis in 1% agarose gels containing 0.66 M formaldehyde. The RNA was then blotted by overnight capillary transfer onto Nytran membranes (Schleicher & Schuell, Keene, NH, USA), and crosslinked by exposure to UV light. The membranes were then prehybridized, hybridized and washed according to standard procedures.
Transient expression of the IL-19 peptide
Two expression plasmids were constructed to determine whether IL-19 was secreted. 33, 59, 60 One plasmid was designed to produce IL-19 tagged with the FLAG epitope at the N′ terminus and the other to tag IL-19 at the Cterminus. In the first construct the fragment encoding the signal peptide of the human IFN-␥ receptor 2 (IFN-␥R2) followed by the FLAG epitope was fused with the fragment encoding the mature IL-19 starting after the predicted signal peptide at Ser19. and the pFL-CRF plasmid DNA as a template, 33 into EcoRI and XbaI sites of the pcDEF3 plasmid. 60 Thus, in the second construct the FLAG epitope was linked to the C-terminus of IL-19 retaining its own signal peptide. Both plasmids were transiently transfected into COS-1 [61] [62] [63] cells and 3 days after transfection the conditioned media were subjected to Western blotting with anti-FLAG antibody. Both constructs were able to drive the expression of the modified IL-19 derivatives.
